Your browser doesn't support javascript.
loading
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Libura, Marta; Bialopiotrowicz, Emilia; Giebel, Sebastian; Wierzbowska, Agnieszka; Roboz, Gail J; Piatkowska-Jakubas, Beata; Pawelczyk, Marta; Gorniak, Patryk; Borg, Katarzyna; Wojtas, Magdalena; Florek, Izabella; Matiakowska, Karolina; Jazwiec, Bozena; Solarska, Iwona; Noyszewska-Kania, Monika; Piechna, Karolina; Zawada, Magdalena; Czekalska, Sylwia; Salamanczuk, Zoriana; Karabin, Karolina; Wasilewska, Katarzyna; Paluszewska, Monika; Urbanowska, Elzbieta; Gajkowska-Kulik, Justyna; Semenczuk, Grazyna; Rybka, Justyna; Wrobel, Tomasz; Ejduk, Anna; Kata, Dariusz; Grosicki, Sebastian; Robak, Tadeusz; Pluta, Agnieszka; Kominek, Agata; Piwocka, Katarzyna; Pyziak, Karolina; Sroka-Porada, Agnieszka; Wrobel, Anna; Przybylowicz, Agnieszka; Wojtaszewska, Marzena; Lewandowski, Krzysztof; Gil, Lidia; Piekarska, Agnieszka; Knopinska, Wanda; Bolkun, Lukasz; Warzocha, Krzysztof; Kuliczkowski, Kazimierz; Sacha, Tomasz; Basak, Grzegorz; Jedrzejczak, Wieslaw Wiktor; Holowiecki, Jerzy.
Afiliación
  • Libura M; Medical University of Warsaw, Warsaw, Poland. marta.libura@gmail.com.
  • Bialopiotrowicz E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Giebel S; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Wierzbowska A; Medical University of Lodz, Lodz, Poland.
  • Roboz GJ; Weil Cornell Medical College, New York, NY, USA.
  • Piatkowska-Jakubas B; New York Presbyterian Hospital, New York, NY, USA.
  • Pawelczyk M; Faculty of Medicine, Jagiellonian University, Cracow, Poland.
  • Gorniak P; Medical University of Warsaw, Warsaw, Poland.
  • Borg K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Wojtas M; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Florek I; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Matiakowska K; Faculty of Medicine, Jagiellonian University, Cracow, Poland.
  • Jazwiec B; Faculty of Medicine, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
  • Solarska I; Medical University of Wroclaw, Wroclaw, Poland.
  • Noyszewska-Kania M; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Piechna K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Zawada M; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Czekalska S; Faculty of Medicine, Jagiellonian University, Cracow, Poland.
  • Salamanczuk Z; Faculty of Medicine, Jagiellonian University, Cracow, Poland.
  • Karabin K; Hopitaux Universitaires de Geneve, Geneve, Switzerland.
  • Wasilewska K; Medical University of Warsaw, Warsaw, Poland.
  • Paluszewska M; Medical University of Lodz, Lodz, Poland.
  • Urbanowska E; Medical University of Warsaw, Warsaw, Poland.
  • Gajkowska-Kulik J; Medical University of Warsaw, Warsaw, Poland.
  • Semenczuk G; Nicolaus Copernicus Municipal Specialist Hospital, Torun, Poland.
  • Rybka J; Dr Biziel University Hospital, Bydgoszcz, Poland.
  • Wrobel T; Medical University of Wroclaw, Wroclaw, Poland.
  • Ejduk A; Medical University of Wroclaw, Wroclaw, Poland.
  • Kata D; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Grosicki S; Medical University of Silesia, Katowice, Poland.
  • Robak T; Department of Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland.
  • Pluta A; Medical University of Lodz, Lodz, Poland.
  • Kominek A; Medical University of Lodz, Lodz, Poland.
  • Piwocka K; Laboratory of Cytometry, Nencki Institute of Experimental Biology, Warsaw, Poland.
  • Pyziak K; Laboratory of Cytometry, Nencki Institute of Experimental Biology, Warsaw, Poland.
  • Sroka-Porada A; Ryvu Therapeutics S.A., Cracow, Poland.
  • Wrobel A; Ryvu Therapeutics S.A., Cracow, Poland.
  • Przybylowicz A; Ryvu Therapeutics S.A., Cracow, Poland.
  • Wojtaszewska M; Ryvu Therapeutics S.A., Cracow, Poland.
  • Lewandowski K; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Gil L; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Piekarska A; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Knopinska W; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Bolkun L; Department of Hematology, Hospital of the Ministry of Internal Affairs and Administration with Regional Oncology Center, Olsztyn, Poland.
  • Warzocha K; Department of Hematology, Medical University of Bialystok, Bialystok, Poland.
  • Kuliczkowski K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Sacha T; Medical University of Wroclaw, Wroclaw, Poland.
  • Basak G; Faculty of Medicine, Jagiellonian University, Cracow, Poland.
  • Jedrzejczak WW; Medical University of Warsaw, Warsaw, Poland.
  • Holowiecki J; Medical University of Warsaw, Warsaw, Poland.
Sci Rep ; 11(1): 10017, 2021 05 11.
Article en En | MEDLINE | ID: mdl-33976256
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Isocitrato Deshidrogenasa / Antineoplásicos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Isocitrato Deshidrogenasa / Antineoplásicos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Polonia